Thursday, May 21, 2009
07:00 SESSION I: Will Endovascular Technology Indulge All Thoracic Pathology?
08:40 SESSION II: The Unknown Knowns in AAA Repair
10:30 COFFEE BREAK
11:00 SESSION III: Is the Complex Aortic Neck a True Reality or a Virtual Dilemma?
12:15 SESSION IV: Modular Devices: The Reality of Endoleak
13:00 LUNCH
Friday, May 22, 2009
07:00 SESSION X: The SFA: Have We Found the Optimal Therapy?
08:45 SESSION XI: Tibial Artery Disease: How Far Can You Go?
10:00 COFFEE BREAK
10:30 SESSION XII: Carotid Artery Disease: Is CAS Safe for Routine Practice?
13:15 LUNCH
14:00 SESSION V: The Great Aortic Debates
15:00 SESSION VI: Viseral Arteries: An Inconvenience in the Endovascular Era?
16:00 SESSION VII: Optimal Medical Management
17:00 COFFEE BREAK
17:00 SESSION VIII: Venous Disease Forum
18:10 SESSION IX: Miscellaneous Topics: From Vascular Access to Wound Closure
14:00 SESSION XIII: Vascular Innovation: From Stem Cells to Robots
15:00 SESSION XIV: The Business of Vascular Surgery: How to Manage Our Future
16:00 COFFEE BREAK
16:20 SESSION XV: Bioconvergence: A Model to Deliver Excellence in Healthcare
17:20 SESSION XVI: Bioconvergence: A Catalyst for Innovation
